Hot Selling for 4-Methoxybenzoyl Chloride Cas 100-07-2 - Imidocarb Powder CAS27885-92-3 – Kaimubuke
Hot Selling for 4-Methoxybenzoyl Chloride Cas 100-07-2 - Imidocarb Powder CAS27885-92-3 – Kaimubuke Detail:
Use of the mido card
This product is an antipyridiosis drug, which has the characteristics of high efficacy, low toxicity and small dose. The severe infection of cattle, sheep and babesiosis was treated with imidazolamide, the disease could be controlled quickly, and no recurrence was found after three months of treatment. The product also has a preventive effect on coke worm disease.
CAS No. |
27885-92-3 |
Other Names |
Imidocarb |
MF |
C19H20N6O |
EINECS No. |
27885-92-3 |
Place of Origin |
China |
China |
Wuhan |
Type |
Antidote |
Grade Standard |
Cosmetic Grade |
Usage |
Animal Pharmaceuticals |
Brand Name |
Richest |
Model Number |
Richest-0822 |
Purity |
99% |
Molecular weight |
458.436g/mol |
Package |
Box |
EINECS No |
227-273-0 |
Appearance |
White Powder |
Storage |
Store |
Application |
Pharmaceuticals |
Molecular Formula |
C14H11F3N2O2 C7H17NO5 |
Color |
Clear |
Composition |
10% 20% |
Product detail pictures:
Related Product Guide:
carry on to boost, to guarantee products excellent in line with market and consumer standard specifications. Our enterprise has a quality assurance system are actually established for Hot Selling for 4-Methoxybenzoyl Chloride Cas 100-07-2 - Imidocarb Powder CAS27885-92-3 – Kaimubuke , The product will supply to all over the world, such as: Birmingham, Oslo, Sydney, Our company sticks to the principle of "high quality, reasonable price and timely delivery". We sincerely hope to establish good cooperative relationships with our new and old business partners from all parts of the world. We hope to work with you and serve you with our excellent goods and services. Welcome to join us!
By Janet from Netherlands - 2018.09.16 11:31
The goods are very perfect and the company sales manager is warmful, we will come to this company to purchase next time.
By Caroline from Bangladesh - 2017.05.02 18:28